Login / Signup

Low levels of anti-SARS-CoV-2 antibodies after vaccination in rituximab- treated patients: Comment on article of Simon et al.

Gerasimos EvangelatosKonstantina KounaGeorge E FragoulisMelina MoschopoulouMaria TriantafylliAntigoni LekkaAlexios Iliopoulos
Published in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
Keyphrases
  • sars cov
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • patient reported outcomes